SCHEMBL2198077

SCHEMBL2198077

Cc1cc(F)ccc1Nc1ccc(C(=O)c2cc(C(=O)N(C)CC3CCCO3)ccc2C)c(Cl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 4/20 0.54
MAPK12 P53778 4/20 0.54
MAPK11 Q15759 4/20 0.54
MAPK14 Q16539 4/20 0.54
NAMPT P43490 4/20 0.50
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.44
OXTR P30559 3/20 0.43
AVPR1A P37288 3/20 0.43
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2198281 0.86 MAPK13 (0.55) MAPK13MAPK12MAPK11MAPK14NAMPT
SCHEMBL2196099 0.81 NAMPT (0.43) NAMPTNPC1POLBRAB9AOXTR
SCHEMBL2199941 0.79 MAPK14 (0.64) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2200850 0.75 MAPK14 (0.61) MAPK13MAPK12MAPK11MAPK14RAB9A
SCHEMBL2198608 0.74 MAPK14 (0.64) MAPK13MAPK12MAPK11MAPK14POLB
SCHEMBL2195435 0.73 MAPK14 (0.55) MAPK13MAPK12MAPK11MAPK14OXTR
SCHEMBL2856599 0.73 MAPK14 (0.74) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2198570 0.72 MAPK14 (0.62) MAPK13MAPK12MAPK11MAPK14AVPR1A
SCHEMBL2197033 0.72 MAPK14 (0.62) MAPK13MAPK12MAPK11MAPK14OXTR
SCHEMBL2198601 0.72 MAPK13 (0.63) MAPK13MAPK12MAPK11MAPK14NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.